Reversal of graft dysfunction following treatment of urinary tract infections in renal transplant recipients

Authors

  • Mehak Abro Sindh Institute of Urology and Transplantation, Karachi Pakistan
  • Ejaz Ahmed Sind Institute of Urology and Transplantation, Karachi Pakistan
  • Ranjeet Kumar Sind Institute of Urology and Transplantation, Karachi Pakistan
  • Imran Ali Sind Institute of Urology and Transplantation, Karachi Pakistan
  • Sidra German Sind Institute of Urology and Transplantation, Karachi Pakistan
  • Huda Narejo Sind Institute of Urology and Transplantation, Karachi Pakistan

DOI:

https://doi.org/10.61529/idjp.v35i2.527

Abstract

Background: UTI is one of the most common complications of the renal transplant recipients. The aim of the study is to assess the reversal of graft malfunction following the management of urinary tract infection in kidney transplant patients.

Material and Methods: This was a prospective observational cohort study done at the Department of Transplant Nephrology, Sindh Institute of Urology and Transplantation. Non-probability consecutive sampling was used to select a total of 70 renal transplant recipients aged between 18 - 65 years with UTI and graft dysfunction. Graft dysfunction reversal was measured at 6 weeks of antibiotic treatment and was divided into complete, partial, and no reversal. The analysis of data was performed by SPSS 22.0 with p<0.05 as significant value.

Results: Graft dysfunction reversal was complete in 38 out of 70 patients (54.3%), partial in 20 out of 70 (28.6%), and absent in 12 out of 70 (17.1%). On multivariable logistic regression analysis, diabetes mellitus (AOR = 0.38, p = 0.041), hypertension (AOR = 0.42, p = 0.048), high baseline creatinine ≥2 mg/dL (AOR = 0.31, p = 0.023), and infection with multidrug-resistant organisms (AOR = 0.56, p = 0.019) were independently associated with decreased odds of complete reversal. The most frequent pathogens were Escherichia coli (32/70, 45.7%) and Klebsiella pneumoniae (18/70, 25.7%).

Conclusions: Graft dysfunction related to UTI is reversible in a high percentage of renal transplant recipients. Comorbidities, impaired baseline renal, and multidrug-resistant infections have a negative impact on recovery.

Keywords: Creatinine; Drug Resistance, Graft Dysfunction, Kidney Transplantation.

References

Pinchera B, Trucillo E, D’Agostino A, Gentile I. Urinary tract infections in kidney transplant patients: An open challenge—update on epidemiology, risk factors and management. Microorganisms. 2024; 12(11): 2217. DOI: https://doi.org/10.3390/microorganisms12112217

Andrade-Sierra J, et al. A five-year retrospective study on urinary tract infections and graft outcomes in kidney transplant recipients. Front Med. 2025; 12: 1606224. DOI: https://doi.org/10.3389/fmed.2025.1606224

Elhoweris AE, Sullivan M, Norton W, Salim E, Aitken E. The natural history and impact of urinary tract infections in kidney transplant recipients. Transplant Proc. 2026; 58(3): 472–81. DOI: https://doi.org/10.1016/j.transproceed.2026.01.026

Al Tamimi AR, Alotaibi WS, Aljohani RM, Aldharman SS, Alharbi NM, Khair HS. The impact of urinary tract infections in kidney transplant recipients: A six-year single-center experience. Cureus. 2023; 15(8): e44458.

DOI: https://doi.org/10.7759/cureus.44458

Anwar I, Rafiq S, Ahmad K, Mubeen MU, Mudassar A, Kamran M. Antimicrobial susceptibility pattern of E. Coli in patients with urinary tract infection at a tertiary care hospital, Rawalpindi. Pak J Med Health Sci. 2022; 16(06): 967. DOI: https://doi.org/10.53350/pjmhs22166967

Halskov ACL, Dagnæs-Hansen J, Stroomberg HV, Sørensen SS, Røder A. et al. Incidence and risk factors for recurrent urinary tract infections in renal transplant recipients. Eur Urol Open Sci. 2023; 48: 35–42. DOI: https://doi.org/10.1016/j.euros.2023.04.001

Meena P, et al. Urinary tract infection in renal transplant recipients: incidence and outcomes. Saudi J Kidney Dis Transpl. 2021; 32(2): 341–7. DOI: https://doi.org/10.4103/1319-2442.335441

Pacaud M, Colas L, Kerleau C, Le Borgne F, Giral M, Brouard S, et al. Impact of late and recurrent acute graft pyelonephritis on long-term kidney graft outcomes. Front Immunol. 2022; 13: 824425. DOI: https://doi.org/10.3389/fimmu.2022.824425

Gołębiewska JE, Krawczyk B, Wysocka M, Dudziak A, Dębska-Ślizień A. Asymptomatic bacteriuria in kidney transplant recipients: Current evidence. Medicina. 2023; 59(2): 198. DOI: https://doi.org/10.3390/medicina59020198

Krawczyk B, Wysocka M, Michalik M, Gołębiewska J. Urinary tract infections caused by Klebsiella pneumoniae in kidney transplant recipients. Front Cell Infect Microbiol. 2022; 12: 861374. DOI: https://doi.org/10.3389/fcimb.2022.861374

Aksoy Gk, Koyun M, Dinckan A, Aliosmanoglu I, Gemici A, Gultekin E, et al. Graft survival in patients with lower urinary tract dysfunction. Exp Clin Transplant. 2021; 19(2): 125-30. DOI: https://doi.org/10.6002/ect.2018.0029

Kawalec A, Zwolińska D. Emerging role of microbiome in the prevention of urinary tract infections in children. Int J Mol Sci. 2022; 23(2): 870. DOI: https://doi.org/10.3390/ijms23020870

Santithanmakorn C, Vanichanan J, Townamchai N, Jutivorakool K, Wattanatorn S, Sutherasan M, et.al. Bacterial urinary tract infection and early asymptomatic bacteriuria in kidney transplantation still negatively affect kidney transplant outcomes in the era of modern immunosuppression and cotrimoxazole prophylaxis. Biomedicines. 2022; 10: 2984. DOI: https://doi.org/10.3390/biomedicines10112984

Bharuka V, Meshram R, Munjewar PK. Comprehensive review of urinary tract infections in renal transplant recipients: clinical insights and management strategies. Cureus. 2024; 16(2): e53882. DOI: https://doi.org/10.7759/cureus.53882

Hosseinpour M, Pezeshgi A, Mahdiabadi MZ, Sabzghabaei F, Hajishah H, Mahdavynia S. Prevalence and risk factors of urinary tract infection in kidney recipients: a meta-analysis study. BMC Nephrol. 2023; 24: 284. DOI: https://doi.org/10.1186/s12882-023-03338-4

Zaman M, Ahmad S, Idrees N, Ahmad F, Naseer S, Gul R. Causative organisms and antimicrobial sensitivity pattern in patients with urinary tract infection. Pak J Health Sci. 2025; 6(5): 141–6. DOI: https://doi.org/10.54393/pjhs.v6i5.3052

Majumder MM, Mahadi AR, Ahmed T, Ahmed M, Uddin MN, Alam MZ. Antibiotic resistance pattern of microorganisms causing urinary tract infection: A 10-year comparative analysis in a tertiary care hospital of Bangladesh. Antimicrob Resist Infect Control. 2022; 11(1): 156. DOI: https://doi.org/10.1186/s13756-022-01197-6 .

Al-Awkally NA, Ibrahim HK, Ali MD, Muthanna FM, Al-Awkally AM, Yousuf A. Study of antibiotic sensitivity pattern in urinary tract infection. Int J Health Sci. 2022; 6(S3): 8896-913. Doi: https://doi.org/10.53730/ijhs.v6nS3.8113 .

Silva A, Costa E, Freitas A, Almeida A. Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections. Antibiotics. 2022; 11(6): 768. DOI: https://doi.org/10.3390/antibiotics11060768

Delay A, Moranne O, Fafin C, Mariat C, Alamartine E, Delanaye P, Maillard N. Relationship between decline in estimated or measured glomerular filtration rate and 16-year postrenal transplant outcome. Clin Kidney J. 2021; 14(6): 1665–72. DOI: https://doi.org/10.1093/ckj/sfaa203

Downloads

Published

30-06-2026

How to Cite

Abro, M., Ahmed, E., Kumar, R., Ali, I., German, S., & Narejo, H. (2026). Reversal of graft dysfunction following treatment of urinary tract infections in renal transplant recipients. Infectious Diseases Journal of Pakistan, 35(2), 83–88. https://doi.org/10.61529/idjp.v35i2.527